Literature DB >> 4031843

The relationship of free and conjugated catecholamines in plasma and cerebrospinal fluid in cerebral and meningeal disease.

D Ratge, W Bauersfeld, H Wisser.   

Abstract

The concentration of free and conjugated norepinephrine (NE), epinephrine (E) and dopamine (DA) were measured by a modified radio-enzymatic assay in the plasma and in the cerebrospinal fluid (CSF) of 45 patients with normal and in 21 patients with disturbed blood-CSF barriers. In patients with an undisturbed blood-CSF barrier the free NE and E in CSF were 128 +/- 45 ng/l and 27 +/- 20 ng/l (mean values +/- S.E.), respectively, and represented about 50% of the average plasma values. Mean DA was not different in plasma (47 +/- 22 ng/l) and in CSF (41 +/- 19 ng/l). Both in plasma and in CSF, considerable higher free catecholamine (CA) levels were measured in patients with dysfunction of the blood-CSF barrier. In one patient with bacterial meningitis twofold higher concentrations of free NE and DA in CSF as compared with plasma were detectable. Sulfate conjugates of catecholamines are predominant in plasma and CSF. The contribution of conjugated CA to total CA in plasma from patients with normal blood-CSF barrier averaged 69.7%, 63.1% and 98.1% for NE, E and DA, respectively and was significantly lower in the CSF (p less than 0.001). In patients with disturbed blood-CSF barrier, the increases of conjugated CA were more pronounced in CSF than in plasma. Further, the contribution of conjugated NE and E to total NE and E in CSF was not only increased in patients with bacterial meningitis, but also in patients with renal insufficiency compared to the "control" patients (p less than 0.02 and p less than 0.001 resp.). Free and conjugated NE, E and DA in the plasma and CSF were related significantly (p less than 0.01 resp.) with stronger correlation for conjugated CA (p less than 0.001 resp.). These results together with findings in the literature, suggest that there is little or no rostral-caudal gradient in CSF CA conjugate concentrations and that even in patients with intact blood-CSF barrier plasma conjugated CA concentrations influence those in CSF. Thus only free CA levels in CSF may reflect the central adrenergic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031843     DOI: 10.1007/bf01252241

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  32 in total

1.  Daily rhythm in the noradrenaline content of rat hypothalamus.

Authors:  J Manshardt; R J Wurtman
Journal:  Nature       Date:  1968-02-10       Impact factor: 49.962

2.  Diurnal changes in brain noradrenalin.

Authors:  D J Reis; R J Wurtman
Journal:  Life Sci       Date:  1968-01-01       Impact factor: 5.037

3.  Circadian rhythm in cerebrospinal fluid noradrenaline of man and monkey.

Authors:  M C Ziegler; C R Lake; J H Wood; M H Ebert
Journal:  Nature       Date:  1976-12-16       Impact factor: 49.962

4.  The convulsive effects of dopamine sulfate conjugates in rat brain.

Authors:  N T Buu; J Duhaime; O Kuchel; J Genest
Journal:  Life Sci       Date:  1981-11-30       Impact factor: 5.037

5.  Altered circadian rhythm of catecholamines in patients with apallic syndrome.

Authors:  D Ratge; E Knoll; U Diener; A Hadjidimos; H Wisser
Journal:  Experientia       Date:  1981-11-15

6.  Presence, distribution and pharmacology of conjugated catecholamines in the rat spinal cord.

Authors:  F Karoum
Journal:  Brain Res       Date:  1983-01-24       Impact factor: 3.252

7.  Plasma free and conjugated catecholamines in diagnosis and localisation of pheochromocytoma.

Authors:  D Ratge; G Baumgardt; E Knoll; H Wisser
Journal:  Clin Chim Acta       Date:  1983-08-31       Impact factor: 3.786

8.  Quantitative localization of biogenic amines in the spinal cord.

Authors:  J A Zivin; J L Reid; J M Saavedra; I J Kopin
Journal:  Brain Res       Date:  1975-12-05       Impact factor: 3.252

9.  Single-isotope enzymatic derivative method for measuring catecholamines in human plasma.

Authors:  J Bosak; E Knoll; D Ratge; H Wisser
Journal:  J Clin Chem Clin Biochem       Date:  1980-07

10.  Studies on the sulphation of 3,4-dihydroxyphenylethylamine (dopamine) and related compounds by rat tissues.

Authors:  W N Jenner; P A Rose
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

View more
  3 in total

Review 1.  Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.

Authors:  Guillermo Gervasini; Juan Antonio Carrillo; Julio Benitez
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates.

Authors:  Tina Suominen; Päivi Uutela; Raimo A Ketola; Jonas Bergquist; Lars Hillered; Moshe Finel; Hongbo Zhang; Aki Laakso; Risto Kostiainen
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 3.  The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.

Authors:  Mohamed Ouzzine; Sandrine Gulberti; Nick Ramalanjaona; Jacques Magdalou; Sylvie Fournel-Gigleux
Journal:  Front Cell Neurosci       Date:  2014-10-28       Impact factor: 5.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.